Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
IV Erwinaze
print preview
bookmark
share with colleague
General Information
Company
Jazz Pharmaceuticals plc
Description
IV formulation of Erwinia chrysanthemi-derived asparaginase
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Acute lymphoblastic leukemia (ALL)
Partner
Ohara Pharmaceutical Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information